News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Agger Mette Kirstine
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 17,300 options to buy
@ $11.71, valued at
$202.6k
|
|
| 06/11/2020 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $7.96, valued at
$48.7k
|
|
| 03/16/2020 |
4
| Agger Mette Kirstine (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Converted 1,245,222 shares
@ $0
Bought 187,500 shares
@ $16, valued at
$3M
Converted 478,749 options to buy
@ $0
Converted 5,470,492 preferred shares
@ $0
Converted 1,894,444 preferred shares
@ $0
Granted 15,457 options to buy
@ $16, valued at
$247.3k
|
|
| 06/20/2019 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $3.37, valued at
$20.6k
|
|
| 05/13/2019 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Converted 776,544 shares
@ $0
Bought 375,000 shares
@ $10, valued at
$3.8M
Converted 6,849,315 preferred shares
@ $0 |
|
| 05/08/2019 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 23,684 options to buy
@ $10, valued at
$236.8k
|
|
| 06/21/2018 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Granted 6,124 options to buy
@ $5.53, valued at
$33.9k
|
|
| 11/21/2017 |
4
| Agger Mette Kirstine (Director) has filed a Form 4 on scPharmaceuticals Inc.|
Txns:
| Converted 1,544,858 shares
@ $0
Converted 984,366 shares
@ $0
Converted 11,092,383 preferred shares
@ $0
Converted 7,067,945 preferred shares
@ $0 |
|
|
|